Sự chết tế bào gan được trung gian bởi độc tính Fas/FasLigand phụ thuộc TNFα trong một mô hình chuột của suy gan cấp tính

Khashab M, Tector AJ, Kwo PY (2007) Epidemiology of acute liver failure. Curr Gastroenterol Rep 9:66–73. doi:10.1007/s11894-008-0023-x Schattenberg JM, Galle PR, Schuchmann M (2006) Apoptosis in liver disease. Liver Int 26:904–911. doi:10.1111/j.1478-3231.2006.01324.x Faubion WA, Gores GJ (1999) Death receptors in liver biology and pathobiology. Hepatology 29:1–4. doi:10.1002/hep.510290101 Kondo T, Suda T, Fukuyama H et al (1997) Essential roles of the Fas ligand in the development of hepatitis. Nat Med 3:409–413. doi:10.1038/nm0497-409 Ksontini R, Colagiovanni DB, Josephs MD et al (1998) Disparate roles for TNF-alpha and Fas ligand in concanavalin A-induced hepatitis. J Immunol 160:4082–4089 Josephs MD, Bahjat FR, Fukuzuka K et al (2000) Lipopolysaccharide and d-galactosamine-induced hepatic injury is mediated by TNF-alpha and not by Fas ligand. Am J Physiol Regul Integr Comp Physiol 278:R1196–R1201 Ando K, Hiroishi K, Kaneko T et al (1997) Perforin, Fas/Fas ligand, and TNF-alpha pathways as specific and bystander killing mechanisms of hepatitis C virus-specific human CTL. J Immunol 158:5283–5291 Morikawa A, Sugiyama T, Kato Y et al (1996) Apoptotic cell death in the response of d-galactosamine-sensitized mice to lipopolysaccharide as an experimental endotoxic shock model. Infect Immun 64:734–738 Tagawa Y, Kakuta S, Iwakura Y (1998) Involvement of Fas/Fas ligand system-mediated apoptosis in the development of concanavalin A-induced hepatitis. Eur J Immunol 28:4105–4113. doi:10.1002/(SICI)1521-4141(199812)28:12<4105::AID-IMMU4105>3.0.CO;2-8 Seino K, Kayagaki N, Takeda K et al (1997) Contribution of Fas ligand to T cell-mediated hepatic injury in mice. Gastroenterology 113:1315–1322. doi:10.1053/gast.1997.v113.pm9322527 Freudenberg MA, Galanos C (1991) Tumor necrosis factor alpha mediates lethal activity of killed gram-negative and gram-positive bacteria in d-galactosamine-treated mice. Infect Immun 59:2110–2115 Guy CS, Wang J, Michalak TI (2006) Hepatocytes as cytotoxic effector cells can induce cell death by CD95 ligand-mediated pathway. Hepatology 43:1231–1240. doi:10.1002/hep.21201 Galle PR, Hofmann WJ, Walczak H et al (1995) Involvement of the CD95 (APO-1/Fas) receptor and ligand in liver damage. J Exp Med 182:1223–1230. doi:10.1084/jem.182.5.1223 Philpott NJ, Turner AJ, Scopes J et al (1996) The use of 7-amino actinomycin D in identifying apoptosis: simplicity of use and broad spectrum of application compared with other techniques. Blood 87:2244–2251 Le Minh K, Klemm K, Abshagen K et al (2007) Attenuation of inflammation and apoptosis by pre- and posttreatment of darbepoetin-alpha in acute liver failure of mice. Am J Pathol 170:1954–1963. doi:10.2353/ajpath.2007.061056 Eipel C, Kidess E, Abshagen K et al (2007) Antileukoproteinase protects against hepatic inflammation, but not apoptosis in the response of d-galactosamine-sensitized mice to lipopolysaccharide. Br J Pharmacol 151:406–413. doi:10.1038/sj.bjp.0707230 Leist M, Gantner F, Bohlinger I et al (1995) Tumor necrosis factor-induced hepatocyte apoptosis precedes liver failure in experimental murine shock models. Am J Pathol 146:1220–1234 Wooley PH, Dutcher J, Widmer MB et al (1993) Influence of a recombinant human soluble tumor necrosis factor receptor FC fusion protein on type II collagen-induced arthritis in mice. J Immunol 151:6602–6607 Schafer T, Scheuer C, Roemer K et al (2003) Inhibition of p53 protects liver tissue against endotoxin-induced apoptotic and necrotic cell death. FASEB J 17:660–667. doi:10.1096/fj.02-0774com Galanos C, Freudenberg MA (1993) Mechanisms of endotoxin shock and endotoxin hypersensitivity. Immunobiology 187:346–356 Fecho K, Cohen PL (1998) Fas ligand (gld)- and Fas (lpr)-deficient mice do not show alterations in the extravasation or apoptosis of inflammatory neutrophils. J Leukoc Biol 64:373–383 Watanabe-Fukunaga R, Brannan CI, Copeland NG et al (1992) Lymphoproliferation disorder in mice explained by defects in Fas antigen that mediates apoptosis. Nature 356:314–317. doi:10.1038/356314a0 Adachi M, Watanabe-Fukunaga R, Nagata S (1993) Aberrant transcription caused by the insertion of an early transposable element in an intron of the Fas antigen gene of lpr mice. Proc Natl Acad Sci USA 90:1756–1760. doi:10.1073/pnas.90.5.1756 Drappa J, Brot N, Elkon KB (1993) The Fas protein is expressed at high levels on CD4+CD8+ thymocytes and activated mature lymphocytes in normal mice but not in the lupus-prone strain, MRL lpr/lpr. Proc Natl Acad Sci USA 90:10340–10344. doi:10.1073/pnas.90.21.10340 Mohler KM, Sleath PR, Fitzner JN et al (1994) Protection against a lethal dose of endotoxin by an inhibitor of tumour necrosis factor processing. Nature 370:218–220. doi:10.1038/370218a0 Lehmann V, Freudenberg MA, Galanos C (1987) Lethal toxicity of lipopolysaccharide and tumor necrosis factor in normal and d-galactosamine-treated mice. J Exp Med 165:657–663. doi:10.1084/jem.165.3.657 Tiegs G, Wolter M, Wendel A (1989) Tumor necrosis factor is a terminal mediator in galactosamine/endotoxin-induced hepatitis in mice. Biochem Pharmacol 38:627–631. doi:10.1016/0006-2952(89)90208-6 Su GL, Klein RD, Aminlari A et al (2000) Kupffer cell activation by lipopolysaccharide in rats: role for lipopolysaccharide binding protein and toll-like receptor 4. Hepatology 31:932–936. doi:10.1053/he.2000.5634 Chen LC, Gordon RE, Laskin JD et al (2007) Role of TLR-4 in liver macrophage and endothelial cell responsiveness during acute endotoxemia. Exp Mol Pathol 83:311–326. doi:10.1016/j.yexmp.007.08.015 Ma Y, Liu H, Tu-Rapp H et al (2004) Fas ligation on macrophages enhances IL-1R1-Toll-like receptor 4 signaling and promotes chronic inflammation. Nat Immunol 5:380–387. doi:10.1038/ni1054 Ogasawara J, Watanabe-Fukunaga R, Adachi M et al (1993) Lethal effect of the anti-Fas antibody in mice. Nature 364:806–809. doi:10.1038/364806a0 Guidotti LG, Ishikawa T, Hobbs MV et al (1996) Intracellular inactivation of the hepatitis B virus by cytotoxic T lymphocytes. Immunity 4:25–36. doi:10.1016/S1074-7613(00)80295-2 Strand S, Hofmann WJ, Grambihler A et al (1998) Hepatic failure and liver cell damage in acute Wilson’s disease involve CD95 (APO-1/Fas) mediated apoptosis. Nat Med 4:588–593. doi:10.1038/nm0598-588 Roskams T, Libbrecht L, Van Damme B et al (2000) Fas and Fas ligand: strong co-expression in human hepatocytes surrounding hepatocellular carcinoma; can cancer induce suicide in peritumoural cells? J Pathol 191:150–153. doi:10.1002/(SICI)1096-9896(200006)191:2<150::AID-PATH612>3.0.CO;2-I Woo M, Hakem R, Soengas MS et al (1998) Essential contribution of caspase 3/CPP32 to apoptosis and its associated nuclear changes. Genes Dev 12:806–819. doi:10.1101/gad.12.6.806 Woo M, Hakem A, Elia AJ et al (1999) In vivo evidence that caspase-3 is required for Fas-mediated apoptosis of hepatocytes. J Immunol 163:4909–4916 Fujiwara M, Suemoto H, Muragaki Y et al (2007) Fas-mediated upregulation of vascular endothelial growth factor and monocyte chemoattractant protein-1 expression in cultured dermal fibroblasts: role in the inflammatory response. J Dermatol 34:99–109. doi:10.1111/j.1346-8138.2006.00226.x Eipel C, Bordel R, Nickels RM et al (2004) Impact of leukocytes and platelets in mediating hepatocyte apoptosis in a rat model of systemic endotoxemia. Am J Physiol Gastrointest Liver Physiol 286:G769–G776. doi:10.1152/ajpgi.00275.2003